²é¿´: 1037  |  »Ø¸´: 0

»ù´¡ÉúÎïʵÑéÍâ°

гæ (³õÈëÎÄ̳)

[½»Á÷] ÂöÂçĤÐÂÉúѪ¹Ü¶¯ÎïÄ£Ð͵Ĺ¹½¨

//
¶¯ÎïµÄÑ¡Ôñ


Ö÷ÒªÓÐÊó¡¢ÍúͺïµÈ¡£ÊóÊÇĿǰÓÕµ¼CNVÄ£ÐÍÓ¦ÓÃ×î¹ã·ºµÄʵÑ鶯Îï¡£

Êó

ÊóÓÕµ¼CNVµÄ·¢ÉúÂʽϸߣ¬´óÔ¼ÓÐ60£¥¡«70£¥ÔÚ¹âÄýºó¶Ìʱ¼ä£¨1ÖÜ£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¹âÄý°ßÓ«¹âÉøÂ©10¡«14Ìì´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬±ãÓÚ»ùÒò²Ù×÷£¬¿ÉÓÃÓڹ۲쵥һ»ùÒò¹ý±í´ï»òµÍ±í´ï¶ÔCNVÉú³ÉµÄÓ°Ïì¡£

²»×ãÖ®´¦ÊÇFFAÖй۲쵽µÄÐÂÉúѪ¹ÜÉøÂ©Âʵͣ¬½öΪ28£¥£¬ÇÒÊóµÄÑÛÇò½ÏС£¬²Ù×÷¼¼ÊõÒªÇó¸ß¡£´óÊóºÍСÊóCNVµÄÓÕ·¢ÂÊÎÞÃ÷ÏÔ²îÒ죬СÊóÑÛÇò¸üС£¬²Ù×÷ÒªÇó¸ü¸ß£¬¸üÊÊÓÚ½øÐÐÓйػùÒòÇóý·½ÃæµÄÑо¿¡£

ºï

ʵÑéÐÔºïCNVÄ£ÐÍÓëÈËÀ༲²¡¸Ä±ä¼«ÎªÏàËÆ£¬²»½ö×é֯ѧ¸Ä±äÒ»Ö£¬ÔÚÑÛµ×Ó«¹âËØÑª¹ÜÔìÓ°£¨FFA£©ÖÐÒ²¾ßÓÐÓ«¹âËØÉøÂ©µÄÌØÕ÷¡£ÕâÖÖÐÂÉúѪ¹ÜÒ»°ã·¢ÉúÔÚ¼¤¹â¹âÄýºó4ÖÜ£¬¿É³ÖÐø2¡«52ÖÜ¡£ÔöÉúÒÆÐеÄRPEϸ°û°üÈÆÐÂÉúѪ¹Üºó£¬ÐÂÉúѪ¹ÜÓ«¹âËØÉøÂ©µÄ±íÏÖ»áÔ½À´Ô½²»Ã÷ÏÔ¡£

¾¡¹ÜÕâÖÖÄ£Ð͵õ½ÁËÒ»ÖµÄÈϿɣ¬µ«¶¯ÎïÀ´Ô´ÊÜÏÞ£¬·ÑÓýϸߣ¬CNVÓÕ·¢Ê±¼ä½Ï³¤£¬·¢ÉúÂʵͣ¬ÏÞÖÆÁËÆäÓ¦Óá£

ÍÃ

ÍòúÉúµÄCNVÔÚFFAÖв»¾ßÓÐÓ«¹âËØÉøÂ©µÄÌØÕ÷£¬¼ÓÖ®¿¼Âǵ½ÍõÄÑÛµ×Ѫѭ»·½á¹¹ÓëÈËÀàÓнϴóµÄ²îÒ죬ĿǰÒÑ»ù±¾²»ÓÃÍÃ×ö´ËÀàÄ£ÐÍ¡£

//
ÔìÄ£·½·¨


Ò»
¼¤¹âÓÕµ¼¶¯ÎïÄ£ÐÍ

ÔìÄ£·½·¨£º

½¡¿µ×ØÉ«Å²Íþ´óÊó£¬ÐÛÐÔ£¬ÌåÖÊÁ¿180-200g£¬10%Ë®ºÏÂÈÈ©(0.35mL/100gÌåÖÊÁ¿)¸¹Ç»×¢ÉäÂé×í¡£¸´·½ÍÐßÁ¿¨°·µÎÑÛÒºµãÑÛɢͫ¡£ÑÛǰ·ÅÖõμÓÉÙÁ¿ 1%¼×»ùÏËÎ¬ËØµÄ¸Ç²£Æ¬½Ó´¥½ÇĤ£¬ë´¼¤¹â(²¨³¤647nm£¬¹â°ßÖ±¾¶50um£¬¹¦ÂÊ360mW£¬ÆØ¹âʱ¼ä0.05s)¾àÊÓÅÌ2~3¸öÊÓÅÌÖ±¾¶¾ùÔȹâÄý9¸öµã£¬ÒÔ¼ûµ½ÓÐÆøÅݲúÉúÌáʾBruchĤ±»»÷´©Îª×¼¡£



FFAµÄ¹Û²ì£º

¹âÄýºóµÚ3¡¢7¡¢14¡¢21¡¢30dËæ»úѡȡ4Ö»´óÊóÐÐFFA¼ì²é¡£É¢Í«¼°Âé×í·½·¨Í¬Ç°£¬10%Ó«¹âËØÄÆ×¢ÉäÒº0.5mL/kg¸¹Ç»×¢ÉäºóÁ¢¼´ÐÐFFA¡£FFAͼÏñ·ûºÏÒÔÏÂÌØµã¼´ÈÏΪCNVÐγɣ¬¢ÙÔÚÔìÓ°ÔçÆÚ¼´¶¯ÂöǰÆÚ»ò¶¯ÂöÆÚ¼´ÏÔÓ°¡£¢ÚÓëÊÓÍøÄ¤Ñª¹ÜϵͳûÓÐÁªÏµ¡£¢ÛÓ«¹âËØÑ¸ËÙÉøÂ©£¬ÓÐÒ»¶¨µÄ»ý´æ·¶Î§£¬ºóÆÚÐγɸßÓ«¹âÇø¡£½«¸÷ʱ¼ä¶Î³öÏÖCNV¹âÄý°ßÊýÄ¿Óë¸Ãʱ¼ä¶ÎµÄ¹âÄý°ß×ÜÊýµÄ±ÈÖµ×÷Ϊ¸Ãʱ¶ÎµÄCNV·¢ÉúÂÊ¡£

ºóÐø½øÐй⾵¹Û²ì¡¢×éÖ¯²¡ÀíѧCNVÏà¶Ôºñ¶È²âÁ¿¡¢Í¸Éäµç¾µ¹Û²ì¡£



Óŵ㣺

¼¤¹âÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍ·¢ÉúÂʽϸߣ¬´óԼΪ 60%~70%£¬ÔÚ¹âÄýºó¶ÌÆÚʱ¼ä£¨7d£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¼¤¹â°ßµÄÓ«¹âËØÉøÂ©ÔÚ 10~14d´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬ÊÇĿǰÑÛ¿ÆÓÕµ¼CNV×î³£Óõ͝ÎïÄ£ÐÍ¡£



¶þ
Éú³¤Òò×ÓÓÕµ¼CNVÄ£ÐÍ

°üÀ¨ÊÓÍøÄ¤ÏÂ×¢ÉäÔØÓÐѪ¹ÜÄÚÆ¤Éú³¤Òò×Ó£¨vascular endothelial growth factor£¬VEGF£©»ùÒòµÄÏÙÏà¹Ø²¡¶¾ÔØÌå¡¢ÖØ×éVEGFÃ÷½ºÎ¢Á£ÓÕµ¼CNVÄ£ÐÍ¡¢ÊÓÍøÄ¤ÏÂ×¢Éä¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó£¨basic fibroblastgrowth factor£¬bFGF£©Äý½ºÎ¢Á£ÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÊÓÍøÄ¤ÏÂ×¢ÉäbFGF/Ö¬¶àÌÇÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÂöÂçĤÉÏǻֲÈëbFGFÎ¢ÉøÍ¸±ÃÓÕµ¼ÖíCNVÄ£Ð͵ȡ£ÆäÖÐÊÓÍøÄ¤ÏÂ×¢ÉäÔØÓÐVEGF»ùÒòµÄÏÙÏà¹Ø²¡¶¾£¨adeno-associated virus£¬AAV£©ÔØÌåÓÕµ¼CNVÄ£ÐÍÊǽÏΪÀíÏëµÄÄ£ÐÍ¡£



ÔìÄ£·½·¨1£º

½«2¦Ìl±àÂëÈË VEGF-A165ÏÙ²¡¶¾×¢Éäµ½´óÊóÊÓÍøÄ¤Ï£¬CNV·¢ÉúÂÊΪ95%¡£



ÔìÄ£·½·¨2£º

ÔÚÍÃÑÛÊÓÍøÄ¤ÏÂ×¢Éä5¡Á106IUÔØÓйý±í´ïVEGF-A165ÏÙ²¡¶¾ÔØÌåÓÕµ¼CNVÄ£ÐÍ£¬CNV·¢ÉúÂÊΪ83%¡£



Èý
ת»ùÒò»ò»ùÒòÇóýÓÕµ¼

ת»ùÒòºÍ»ùÒòÇóý½¨Á¢CNVÄ£ÐÍÊÇÒ»ÖÖÐÂÐ˼¼Êõ£¬Õë¶ÔCNV·¢Õ¹µÄ¹Ø¼üÒòËØ½¨Á¢»ùÒò¹¤³ÌÄ£ÐÍ£¬¿É´Ó²»Í¬½Ç¶È·ÖÎö¸÷·Ö×Ó¶ÔCNVÐγɵÄÓ°Ï죬°üÀ¨£º£¨1£©VEGF164RPE65ת»ùÒòСÊ󣻣¨2£©Ë«±¶Ì壨Tet/VMD2/VEGF£©ºÍÈý±¶Ì壨Tet/VMD2/VEGF/An2£©×ª»ùÒòСÊó£¬ÊÓÍøÄ¤¿É¸ß±í´ïVEGF£¬ÈôͬʱÊÓÍøÄ¤ÏÂ×¢ÉäѪ¹ÜÉú³ÉËØ2£¨angiogenin2£¬Ang2£©£¬Äܹ»100%ÐγÉCNV£»£¨3£©Ç÷»¯Òò×ÓCCÀàÊÜÌå2£¨chemokine CC motif receptor 2£¬CCR2£©/Ç÷»¯Òò×ÓCCÀàÅäÌå2£¨chemokine CC motif ligand 2£¬CCL2£©»ùÒòȱʧÓÕµ¼Ð¡ÊóCNVÄ£ÐÍ£¬Æä³ÉÄ£ÂÊ´óÔ¼25£¥£»£¨4£©ÔØÖ¬µ°°×E»ùÒò£¨apolipoprotein E£¬ApoE£©¹ý±í´ïСÊóCNVÄ£ÐÍÊÇÑо¿AMD²¡±äÖÐ×Ô·¢ÐÔCNVÐγɻúÖÆµÄÖØÒªÄ£ÐÍ£»£¨5£©CCL2ºÍCX3CÇ÷»¯Òò×ÓÊÜÌå1£¨CX3C chemokine receptor 1£¬CX3CR1£©»ùÒòȱÏÝСÊ󣻣¨6£©³¬Ñõ»¯ÎïÆç»¯Ã¸1£¨superoxide dismutase 1£¬SOD1£©»ùÒòȱÏÝÀÏ»¯Ð¡Ê󣻣¨7£©¼«µÍÃܶÈÖ¬µ°°×ÊÜÌ壨very low density lipoprotein receptor£¬VLDLR£©¶¨ÏòÍ»±äСÊ󣻣¨8£©ÊÓ×ϺìÖÊ»ùÒòÆô¶¯×Ó/VEGF¹ý±í´ïСÊó¡£


ÓÅȱµã£º

ת»ùÒò»ò»ùÒòÇóýÓÕµ¼µÄCNVÄ£Ð;ßÓÐÓÕµ¼¿ì£¬·¢Éúʱ¼ä¶ÌµÈÓŵ㣬ÓëCNV²¡ÀíÉúÀíѧ¹ØÁªÐÔÇ¿£¬¶ÔCNV·¢Éú»úÖÆµÄÑо¿¾ßÓÐÕë¶ÔÐÔ£¬Í¬Ê±Ñо¿Õ߿ɸù¾Ý²»Í¬ÐèÇóÑ¡ÔñÄ£ÐͲ¢Ð޸IJÎÊý£»È±µãÓÐCNVÓÕµ¼Âʵ͡¢Ãæ»ýС¡¢¼Û¸ñ¹óµÈÎÊÌâ¡£

//
×ܽá


ÔÚÖڶཨÁ¢CNVÄ£Ð͵ķ½·¨ÖУ¬¼¤¹âÓÕµ¼CNVÄ£ÐÍÌõ¼þ½Ï³ÉÊ죬Ñо¿ÀúÊ·¾Ã£¬¿É¿¿ÐԸߣ¬Ó¦Óù㷺¡£ÓÉÓÚ¶¯ÎïÌåÄÚ»·¾³²»Í¬ÓÚÈËÌåÄÚ»·¾³£¬¸÷ÖÖ·½·¨ÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍÒ²½öÄÜÄ£ÄâÈËÀàCNV£¬²»ÄÜÍêÈ«´úÌæÈËÀàCNV·¢Õ¹µÄ×ÔÈ»¹ý³Ì£¬Òò´Ë£¬Ñо¿½á¹û½öÄÜΪCNV·¢²¡ºÍ»úÖÆÑо¿ÌṩʵÑéÀíÂÛÒÀ¾Ý¡£
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ »ù´¡ÉúÎïʵÑéÍâ° µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 jCd0dEvKHShX 2026-08-29 4/200 2026-08-30 13:54 by GkCVyODlx4mR
[ÕÒ¹¤×÷] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 gy1nBQXYQJqL 2026-08-29 8/400 2026-08-30 12:14 by l0VvVHGBGRLv
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.54,¿ÆÄ¿È«,¿ÉÙ¤¼± +4 gy1nBQXYQJqL 2026-08-29 8/400 2026-08-30 12:03 by l0VvVHGBGRLv
[²©ºóÖ®¼Ò] ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +8 ASdOkHsho7FD 2026-08-28 9/450 2026-08-30 11:40 by l0VvVHGBGRLv
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 G6APbkg8SA6w 2026-08-29 4/200 2026-08-30 07:28 by ZPa0EcMwuECS
[½Ìʦ֮¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +5 ASdOkHsho7FD 2026-08-28 7/350 2026-08-30 06:10 by ZPa0EcMwuECS
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼± +4 G6APbkg8SA6w 2026-08-29 5/250 2026-08-30 02:40 by ZPa0EcMwuECS
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +4 gy1nBQXYQJqL 2026-08-29 4/200 2026-08-30 02:09 by ZPa0EcMwuECS
[¿¼²©] ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 gy1nBQXYQJqL 2026-08-29 4/200 2026-08-30 01:34 by ZPa0EcMwuECS
[»ù½ðÉêÇë] Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ +12 Kittylucky 2026-08-27 13/650 2026-08-29 00:04 by superceng
[»ù½ðÉêÇë] Ôõô²é°¡ +6 huang1991js 2026-08-26 6/300 2026-08-28 08:42 by winsaint
[»ù½ðÉêÇë] ÃæÉϺÏ×÷µ¥Î»¸ÇÕ +5 ssyjh 2026-08-27 5/250 2026-08-27 20:50 by gdfollow
[»ù½ðÉêÇë] »ù½ðδÖУ¬ÕâÖÖ´ð¸´ÊÇÄ£°åÂ𣿠+5 zhaosm1982 2026-08-27 6/300 2026-08-27 16:00 by lfy8008
[»ù½ðÉêÇë] Ôõô¿´Çà»ùÖÐÁËûÓа¡ +5 Ò¶¾Å΢ 2026-08-26 5/250 2026-08-27 10:35 by l_zh2008
[»ù½ðÉêÇë] ÎÒ²»Àí½â£¡ +15 Edward_pc 2026-08-26 23/1150 2026-08-26 20:34 by zzuzxg
[»ù½ðÉêÇë] 2026Äê8ÔÂ25ÈÕ¹ú×ÔÈ»·Å°ñǰͻȻÊÕµ½ÁÐÈëÆÀÉóר¼ÒÓʼþ£¬ÓйØÏµÂ𣿠+25 ľˮ˼¶¹ 2026-08-25 28/1400 2026-08-26 14:53 by draco1987
[»ù½ðÉêÇë] ¹ú¼ÊºÏ×÷¿É²éÁË£¬ÖÐÁËÃæÉÏ (EPI+1)(½ð±Ò+50) +18 Ldrop2023 2026-08-26 18/900 2026-08-26 11:15 by cmrandy
[»ù½ðÉêÇë] ¹úºÏ¿É²éÁË +3 paperzjh 2026-08-26 3/150 2026-08-26 10:41 by LemmonTr
[»ù½ðÉêÇë] ½ñÌìÎñί»á¿ªÍêÁË£¬Ã÷Ìì³ö½á¹ûÂð +19 angus9576 2026-08-25 23/1150 2026-08-26 10:03 by zp519
[»ù½ðÉêÇë] ijЩ»ú¹¹£¬ÒÔЧÂʵÍΪÈÙ£¬ÒÔЧÂʵÍ×÷Ϊ´æÔڸР+9 yuleib84 2026-08-25 10/500 2026-08-25 17:14 by alexon
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û